INDUCTION TREATMENT FOLLOWED BY IMMUNOSUPPRESSION WITHDRAWAL IN LIVER TRANSPLANTATION: A COMPARATIVE TRIAL.Tratamiento de inducción y retirada de la inmunosupresión en el trasplante hepático. Estudio comparativo - ATEGE_LIVER
- Conditions
- iver transplantation
- Registration Number
- EUCTR2005-005635-10-ES
- Lead Sponsor
- iver Unit, ICMD, Hospital Clinic Barcelona
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
1-Age > 18 years
2-Recipient of a primary liver graft
3-Absence of any of our exclusion criteriae
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
1-Pretransplant renal failure, defined as serum creatinine > 1,5 mg/dL
2-Severe pretransplant thrombopenia, defined as platelets <50000/mL
3-Combined liver-kidney transplanation
4-Autoimmune hepatitis, primary biliary cirrhosis or primary sclerosing cholangitis as causes of liver transplantation
5-Chronic hepatic encephalopathy
6-Living donor liver transplantation
7-Recipient with human immunodeficiency virus infection
8-Severe pretransplant leukopenia, defined as <1500 leukocytes/mL
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.